BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/3/2026 5:50:21 AM | Browse: 16 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Anti-reflux mucosectomy is associated with better short-term symptoms than double-dose proton pump inhibitor in reflux esophagitis patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Jun Jiang, Jie Liu, Ying-Ling Liu, Meng-Die Tang, Yuan Sheng and Ye-Tao Wang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Scientific Research Plan Project of Universities in Anhui Province |
No. 2024AH052045 |
|
| Corresponding Author |
Ye-Tao Wang, Chief Physician, Department of Gastroenterology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Hefei 230001, Anhui Province, China. wangyt96@163.com |
| Key Words |
Gastroesophageal reflux disease; Anti-reflux mucosectomy; Quality of life; Reflux esophagitis; Proton pump inhibitor |
| Core Tip |
Anti-reflux mucosectomy (ARMS) is an innovative endoscopic technique developed for the management of refractory gastroesophageal reflux disease. The procedure aims to induce submucosal fibrosis following mucosectomy at the esophagogastric junction, offering the advantage of a minimally invasive endoscopic approach. Since its inception, multiple prospective and retrospective studies have been conducted to evaluate the clinical outcomes associated with ARMS. In this context, we present the findings of a retrospective cohort study comparing the efficacy of ARMS to twice-daily proton pump inhibitor (PPI) therapy in a well-defined population of patients exhibiting moderate-to-severe regurgitation despite once-daily PPI treatment. |
| Citation |
Jiang WJ, Liu J, Liu YL, Tang MD, Sheng Y, Wang YT. Anti-reflux mucosectomy is associated with better short-term symptoms than double-dose proton pump inhibitor in reflux esophagitis patients. World J Gastrointest Surg 2026; In press |
 |
Received |
|
2026-02-11 02:36 |
 |
Peer-Review Started |
|
2026-02-11 02:52 |
 |
First Decision by Editorial Office Director |
|
2026-03-03 08:57 |
 |
Return for Revision |
|
2026-03-03 08:57 |
 |
Revised |
|
2026-03-11 11:19 |
 |
Publication Fee Transferred |
|
2026-03-12 10:09 |
 |
Second Decision by Editor |
|
2026-04-03 02:44 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-03 05:50 |
 |
Articles in Press |
|
2026-04-03 05:50 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345